The largest database of trusted experimental protocols

9 protocols using tapi 2

1

LPS-Induced Oxidative Stress Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
HK2 cells were cultured in 24-well plates until they reached confluence. Cells were pre-treated with TAPI1 (1 µM for 30 min pre-trement, Calbiochem) and TAPI2 (10 µM for 1hr pretreatment, Cayman) and then treated with 10 µg/ml of LPS for 8 h. At the end of the experimental periods, cells were preloaded with 10 µM 2′, 7′-dichlorofluorescein diacetate (DCF-DA; Molecular Probes) for 30 min at 37℃. Fluorescence intensity was analyzed by a fluorescence reader (Fluoroscan Ascent FL; Lab systems, Helsinki, Finland) using 485 nm excitation and 538 nm emission filter. HK2 cells were cultured on a 6-well plate for DCF-DA staining. Cells were pre-treated with TAPI1 (1 µM for 30 min) and TAPI2 (10 µM for 1 h) and then treated with 10 µg/ml of LPS for 8 h. Cells were washed twice with hanks balanced salt solution (HBSS) and incubated with HBSS (without phenol red) containing DCF-DA for 30 min at 37℃ in dark. The images were obtained with a fluorescence microscope (Nikon, Tokyo, Japan).
+ Open protocol
+ Expand
2

Fibulin-3 Modulates Notch Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were recovered from culture, lysed and processed for Western blotting using standard protocols (antibodies are listed in Supplementary Table I). For semi-quantitative RT-PCR, cells were processed using Trizol reagent (Life Technologies) and total RNA was purified by ethanol precipitation (primers are listed in Supplementary Table II). For Notch-reporter assays, HBMECs were transfected with the Notch-reporter construct and Renilla luciferase as loading control (9 (link)). Reporter-transfected cells were treated with purified fibulin-3 for 16 h and processed to quantify luciferase activity. To measure alpha-secretase (ADAM10/17) activity, HBMECs were lysed in 50 mM Tricine buffer (pH 7.5) containing 100 mM NaCl, 10 mM CaCl2, 1 mM ZnCl2, and 0.1% Triton X-100. Lysates (50 μg total protein) were incubated with a fluorogenic ADAM10/17 substrate peptide (TACE substrate III, 10 μM; R&D systems, Minneapolis, MN) and development of fluorescence was followed with a microplate reader as recommended by the peptide manufacturer. Cultures were treated for 1 to 16 h with purified fibulin-3 (300 ng/ml), purified TIMP3 (1 μg/ml, Sigma-Aldrich), gamma-secretase inhibitor DAPT (25 μM, Tocris Bioscience, Bristol UK) and alpha-secretase inhibitor TAPI-2 (1 μM, Cayman Chemical, Ann Arbor MI)
+ Open protocol
+ Expand
3

Quantification of TACE activity in cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transfected cells were lysed and processed for semiquantitative RT-PCR or Western blotting using standard protocols16 (link) (antibodies and primers are listed in Suppl. Tables S-I and S-II). Cultures were treated overnight with the gamma-secretase inhibitor DAPT (25 μM, Tocris Bioscience, Bristol UK) or the TACE inhibitor TAPI-2 (1 μM, Cayman Chemical, Ann Arbor MI). Cells were also treated with TNFα (10 ng/ml, Peprotech, Rocky Hill NJ), fibulin-3 (300 ng/ml, Origene, Rockville MD), or the TNFα inhibitor C87 (10 μM, Tocris) for 1 to 24 h before collection. For reporter assays a plasmid carrying Renilla luciferase was co-transfected as loading control.
To measure TACE activity, cells were lysed in 50 mM Tricine buffer (pH 7.5) containing 100 mM NaCl, 10 mM CaCl2, 1 mM ZnCl2 and 0.1% Triton X-100. Clarified lysates (50 μg total protein) were incubated with a fluorogenic ADAM10/17 substrate peptide (TACE substrate III) as described18 (link).
+ Open protocol
+ Expand
4

Endothelial Cell Culture and Blue Light Exposure

Check if the same lab product or an alternative is used in the 5 most similar protocols
bEnd.3 were purchased from the Bioresource Collection and Research Center (BCRC, Hsinchu, Taiwan) and maintained in medium formulation suggested by the American Type Culture Collection (ATCC, Manassas, VA). Primary human retinal microvascular endothelial cells (HREC) and endothelial growth medium were obtained from CellBiologics (Chicago, IL, USA). HREC were grown on gelatin-coated dishes. In the routine protocol, cell culture medium was refreshed every 2 days, and cells were passaged at 80–90% confluence. The main findings of this study were authenticated by both bEnd.3 and HREC. The knockdown of ADAM17 and GNAZ was achieved by transient transfection of the pLKO.1 vector with shRNA target sequences (RNA Technology Platform and Gene Manipulation Core, Academia Sinica, Taiwan). Stable clones were produced using puromycin selection. The TAPI-2 (ADAM17 inhibitor) was acquired from Cayman Chemical Company (Ann Arbor, MI, USA), and the stock was prepared in DMSO. The design of the blue light exposure chamber for in vitro studies is shown in Additional file 1: Fig. S1A. Briefly, blue LEDs were oriented at the bottom of the chamber, and the illuminances (80, 160, and 240 lx) were controlled by setting the distance to the LED-emitting plate. The illuminances used in this study are common among modern 3C displayers (Additional file 1: Fig. S1B).
+ Open protocol
+ Expand
5

CD80-GFP CHO Cells for T Cell Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD80-GFP CHO cells were generated by transduction with lentiviral vectors (CSII-EF-MCS) carrying CMV promotor-driven eGFP-fused mouse CD8029 . The resulting transfectants were sorted (MoFlo XDP, Beckman Coulter) for uniform GFP expression. Naïve CD4+ T cells isolated from the spleen of WT and Rap1KO mice were mixed at a 1:1 ratio with CD80-GFP donor CHO cells for 24 h in the presence of soluble anti-CD3 (5 µg/ml) or PMA (12.5 ng/ml)/ionomycin (100 ng/ml) and TAPI2 (100 µM, Cayman Chemical); BafA (25 nM, AdipoGen) was used for up to 6 h before culture termination. The mixed cells were stained with anti-CD4 and anti-CTLA-4 and analyzed by flow cytometry. The mixed cells were immobilized on poly-L-lysine-coated slides, and confocal images (TCS SP8, Leica) were obtained using a 63x objective lens.
+ Open protocol
+ Expand
6

Quantification of TACE activity in cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transfected cells were lysed and processed for semiquantitative RT-PCR or Western blotting using standard protocols16 (link) (antibodies and primers are listed in Suppl. Tables S-I and S-II). Cultures were treated overnight with the gamma-secretase inhibitor DAPT (25 μM, Tocris Bioscience, Bristol UK) or the TACE inhibitor TAPI-2 (1 μM, Cayman Chemical, Ann Arbor MI). Cells were also treated with TNFα (10 ng/ml, Peprotech, Rocky Hill NJ), fibulin-3 (300 ng/ml, Origene, Rockville MD), or the TNFα inhibitor C87 (10 μM, Tocris) for 1 to 24 h before collection. For reporter assays a plasmid carrying Renilla luciferase was co-transfected as loading control.
To measure TACE activity, cells were lysed in 50 mM Tricine buffer (pH 7.5) containing 100 mM NaCl, 10 mM CaCl2, 1 mM ZnCl2 and 0.1% Triton X-100. Clarified lysates (50 μg total protein) were incubated with a fluorogenic ADAM10/17 substrate peptide (TACE substrate III) as described18 (link).
+ Open protocol
+ Expand
7

HeLa Cell Surface Protein Labeling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human cervical carcinoma cell line HeLa was maintained in Dulbecco's modified Eagle's medium (GIBCO, CA, USA) supplemented with 10% fetal bovine serum (FBS; Wako Pure Chemical Industries, Japan), 100 U/mL penicillin, and 100 μg/mL streptomycin (Sigma-Aldrich, MO, USA) in a humidified atmosphere with 5% CO2 at 37 °C. The medium was replaced twice a week. Cell surface protein-specific labeling was performed using sulfo-cyanine3-NHS ester (sulfo-Cy3-NHS; ab146458, Abcam, UK), sulfo-cyanine5-NHS ester (sulfo-Cy5-NHS; ab146459, Abcam), Cy3-NHS ester (Cy3-NHS; IC3-OSu, Dojindo, Japan), and sulfo-NHS-LC-LC-biotin (21338; Thermo Fisher Scientific, MA, USA). Briefly, living cells were incubated with 50 μM sulfo-Cy3-NHS, sulfo-Cy5-NHS, Cy3-NHS, or sulfo-NHS-LC-LC-biotin at 4 °C for 30 min, washed with PBS, and then incubated in FBS-free medium supplemented with 15 μM ZnCl2. To inhibit ADAM17 activity, TAPI-2 (Cayman Chemical, MI, USA) was added to the medium at a concentration of 100 μM.
+ Open protocol
+ Expand
8

Examining HK-2 Cell Response to LPS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human renal proximal tubular epithelial cells (HK-2 cells, American Type Culture Collection, Manassas, VA) were cultured and passaged every 3–4 days. The detailed condition and media used for cell culture was previously described [11 (link)]. The cells were treated with or without LPS (10 µg/ml) for 8 h. The control cells were treated with a buffer solution alone. TAPI1 (1 µM for 30 min pre-trement, calbiochem, San Diego, CA, USA) or TAPI2 (10 µM for 1 h pre-treatment, Cayman, Ann Arbor, MI, USA) were used as a TACE inhibitor.
+ Open protocol
+ Expand
9

Recombinant HMGB1 Signaling Pathway

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human HMGB1 (1690-HMB, endotoxin less than 0.10 EU/μg) was purchased from R&D Systems (Abingdon, UK). SB203580 and dimethyl sulfoxide (DMSO) were from EMD Chemicals (Darmstadt, Germany). TAPI-2 was from Cayman Chemical (Ann Arbor, MI, USA). Antibodies to human TLR4 (76B357.1: a mouse monoclonal antibody against amino acids 100 -200 of human TLR4), RAGE (sc-80652, a mouse monoclonal antibody against a truncated extracellular domain of human RAGE), p38 mitogen-activated protein kinase (p38 MAPK), ADAM10 and actin were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibodies to human TLR4 (ab13556; a rabbit polyclonal antibody against amino acids 420-435 of human TLR4) and ADAM17 were from Abcam. An antibody to human phospho-p38 MAPK (Thr180/Tyr182) was from Cell Signaling Technology (Denvers, MA, USA).
ADAM17-siRNA, ADAM10-siRNA, RAGE-siRNA, TLR4-siRNA and control-siRNA (Ambion ® ) were from Life Technologies (Paisley, UK). The fluorogenic substrate, 5FAM-Ser-Pro-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg-Lys(5-TAMRA)-NH 2 , was from Enzo Life Sciences, Inc. (Farmingdale, NY, USA). 4',6-Diamidino-2phenylindole dihydrochloride (DAPI) and Ponceau S solution were from Sigma-Aldrich (St. Louis, MO, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!